×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [40]
山东大学 [26]
中国医学科学院 北... [23]
西安交通大学 [12]
昆明医科大学 [6]
武汉大学 [5]
更多...
内容类型
期刊论文 [142]
会议论文 [3]
学位论文 [3]
发表日期
2023 [1]
2021 [1]
2020 [1]
2019 [12]
2018 [25]
2017 [15]
更多...
学科主题
Engineerin... [1]
Materials ... [1]
gastroente... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共148条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study
期刊论文
BMC CANCER, 2023, 卷号: 23
作者:
Cao, Fei
;
Shi, Changsheng
;
Zhang, Guofu
;
Luo, Jun
;
Zheng, Jiaping
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2023/11/10
Hepatocellular carcinoma
Atezolizumab
Bevacizumab
Overall survival
Progression-free survival
Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy
期刊论文
EUROPEAN JOURNAL OF RADIOLOGY, 2021, 卷号: 142, 页码: 8
作者:
Wei, Shengcai
;
Han, Yuqi
;
Zeng, Hanjiang
;
Ye, Shuai
;
Cheng, Jin
收藏
  |  
浏览/下载:69/0
  |  
提交时间:2021/11/03
Histopathologic growth pattern
Colorectal liver metastases
Unresectable
Radiomics
Bevacizumab
Small-sized gadolinium oxide based nanoparticles for high-efficiency theranostics of orthotopic glioblastoma
期刊论文
BIOMATERIALS, 2020, 卷号: 235
作者:
Shen, Zheyu
;
Liu, Ting
;
Yang, Zhen
;
Zhou, Zijian
;
Tang, Wei
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2020/12/16
BLOOD-BRAIN-BARRIER
CONTRAST AGENTS
GOLD NANOPARTICLES
DRUG-DELIVERY
BEVACIZUMAB
THERAPY
T-1
PERMEABILITY
RADIOTHERAPY
TEMOZOLOMIDE
A phase I, randomized, double-blinded, single-dose study evaluating the pharmacokinetic equivalence of the biosimilar IBI305 and bevacizumab in healthy male subjects
期刊论文
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 卷号: 57, 期号: 3
作者:
Li, Cuiyun
;
Zhang, Hong
;
Zhu, Xiaoxue
;
Wei, Haijing
;
Chen, Hong
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2019/12/05
biosimilar
phase I
IBI305
bevacizumab
pharmacokinetics
Capecitabine plus bevacizumab versus capecitabine in maintenance treatment for untreated characterised KRAS exon 2 wild-type metastatic colorectal cancer: a retrospective analysis in Chinese postmenopausal women
期刊论文
BMC GASTROENTEROLOGY, 2019, 卷号: 19
作者:
Yang, Chen
;
Zhao, Mingdong
;
Zhu, Ying
;
Su, Jinsong
;
Yang, Ruikun
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2019/12/05
Capecitabine
Bevacizumab
Colorectal cancer
Progression-free survival
Overall survival
Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy
期刊论文
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 卷号: 14
作者:
Sun, Jian-Guo
;
Jian, Qin
;
Zhang, Xiao-Pei
;
Shan, Kun
;
Liu, Bai-Hui
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2019/12/05
mesoporous silica nanoparticle
bevacizumab
ocular angiogenesis
antiangiogenic therapy
Baseline serum lactate dehydrogenase level predicts survival benefit in patients with metastatic colorectal cancer receiving bevacizumab as first-line chemotherapy: a systematic review and meta-analysis of 7 studies and 1,219 patients
期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2019, 卷号: 7, 期号: 7
作者:
Feng, Wanjing
;
Wang, Yue
;
Zhu, Xiaodong
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/12/05
Lactate dehydrogenase (LDH)
colorectal cancer
bevacizumab
Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: a single-arm meta-analysis based on prospective studies
期刊论文
BMC CANCER, 2019, 卷号: 19
作者:
He, Liyun
;
Deng, Huan
;
Lei, Jun
;
Yi, Fengming
;
Li, Jine
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2019/11/19
Sorafenib
Meta -analysis
Hepatocelkilar carcinoma
Bevacizumab
Erlotinih
First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis
期刊论文
BMC CANCER, 2019, 卷号: 19
作者:
Zheng, Bobo
;
Wang, Xin
;
Wei, Mingtian
;
Wang, Quan
;
Li, Jiang
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/11/19
First line
Metastatic colorectal cancer
Bevacizumab
Cetuximab
Wild type
Oxymatrine enhanced anti-tumor effects of Bevacizumab against triple-negative breast cancer via abating Wnt/beta-Catenin signaling pathway
期刊论文
AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 卷号: 9, 期号: 8
作者:
Zhang, Yan
;
Xie, Wei
;
Zhang, Shiwei
;
Wan, Fengxian
;
Zhang, Kunchi
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
Oxymatrine
bevacizumab
TNBC
EMT
Wnt/beta-Catenin pathway
©版权所有 ©2017 CSpace - Powered by
CSpace